Commerzbank Aktiengesellschaft’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q2
Sell
-3,389
Closed -$286K 104
2020
Q1
$286K Sell
3,389
-4,077
-55% -$344K 0.01% 334
2019
Q4
$631K Buy
7,466
+241
+3% +$20.4K 0.01% 504
2019
Q3
$487K Buy
7,225
+1,949
+37% +$131K ﹤0.01% 628
2019
Q2
$452K Buy
5,276
+586
+12% +$50.2K ﹤0.01% 630
2019
Q1
$417K Buy
4,690
+279
+6% +$24.8K ﹤0.01% 621
2018
Q4
$376K Sell
4,411
-259
-6% -$22.1K ﹤0.01% 635
2018
Q3
$453K Sell
4,670
-4,755
-50% -$461K ﹤0.01% 662
2018
Q2
$888K Sell
9,425
-1,359
-13% -$128K 0.01% 534
2018
Q1
$874K Buy
10,784
+3,739
+53% +$303K 0.01% 542
2017
Q4
$628K Buy
7,045
+4,175
+145% +$372K 0.01% 581
2017
Q3
$267K Sell
2,870
-1,292
-31% -$120K ﹤0.01% 681
2017
Q2
$378K Sell
4,162
-51,254
-92% -$4.65M 0.01% 538
2017
Q1
$4.86M Sell
55,416
-64,674
-54% -$5.68M 0.07% 211
2016
Q4
$9.95M Sell
120,090
-7,957
-6% -$659K 0.15% 123
2016
Q3
$11.8M Sell
128,047
-49,196
-28% -$4.55M 0.19% 102
2016
Q2
$13.8K Buy
177,243
+119,149
+205% +$9.27K 0.09% 120
2016
Q1
$4.79M Sell
58,094
-37,388
-39% -$3.08M 0.04% 238
2015
Q4
$10M Sell
95,482
-8,913
-9% -$934K 0.08% 157
2015
Q3
$11M Buy
104,395
+44,016
+73% +$4.64M 0.08% 138
2015
Q2
$8.26M Sell
60,379
-129,942
-68% -$17.8M 0.04% 217
2015
Q1
$23.7M Buy
190,321
+4,411
+2% +$550K 0.14% 98
2014
Q4
$16.8M Buy
185,910
+45,843
+33% +$4.14M 0.11% 133
2014
Q3
$10.1M Buy
140,067
+80,851
+137% +$5.83M 0.04% 277
2014
Q2
$3.68M Buy
59,216
+10,029
+20% +$624K 0.02% 500
2014
Q1
$3.36M Sell
49,187
-35,474
-42% -$2.42M 0.01% 517
2013
Q4
$5.83M Sell
84,661
-409,763
-83% -$28.2M 0.03% 356
2013
Q3
$35.7M Buy
494,424
+472,508
+2,156% +$34.1M 0.18% 101
2013
Q2
$1.22M Buy
+21,916
New +$1.22M 0.01% 759